Funding Rounds
Somagenetix

Somagenetix Series A Round, October 2024

Somagenetix

Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $11.66M

Raised Date: 2024-10-10

Investors